Global Antibiotics Market 2020-2030 by Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Route of Administration, Drug Type, and Region: Trend Forecast and Growth Opportunity

About the Report

About the Report

Global antibiotics market will reach USD 63.99 billion by 2030, growing by 3.5% annually over 2020-2030 driven by rising incidences of bacterial infection, growing awareness and need for new drugs and treatment amid the COVID-19 epidemic.

Highlighted with 86 tables and 93 figures, this 182-page report Global Antibiotics Market 2020-2030 by Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Route of Administration, Drug Type, and Region: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire global antibiotics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure

Growth Drivers

Restraints and Challenges

Emerging Product Trends & Market Opportunities

Porter's Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global antibiotics market in every aspect of the classification from perspectives of Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Route of Administration, Drug Type, and Region.

Based on Drug Class, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Cephalosporin

Penicillin

Macrolides

Fluoroquinolones

Quinolones

Monobactam

Aminoglycosides

Carbapenem

Other Drug Classes

Based on Action Mechanism, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Cell Wall Synthesis Inhibitors

Mycolic Acid Inhibitors

RNA Synthesis Inhibitors

DNA Synthesis Inhibitors

Protein Synthesis Inhibitors

Other Mechanisms

Based on Drug Origin, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Natural Antibiotics

Semi-synthetic Antibiotics

Synthetic Antibiotics

Based on Activity Spectrum, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Broad-spectrum Antibiotics

Narrow-spectrum Antibiotics

Based on Route of Administration, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Oral Administration

Intravenous Administration

Other Administration Routes

Based on Drug Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Brand Antibiotics

Generic Antibiotics

Geographically, the following regions together with the listed national/local markets are fully investigated:

APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)

Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)

North America (U.S., Canada, and Mexico)

South America (Brazil, Chile, Argentina, Rest of South America)

RoW (Saudi Arabia, UAE, South Africa)

For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Drug Class, Drug Origin, and Route of Administration over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in global antibiotics market are assayed quantitatively and qualitatively through GMD's Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):

Abbott Laboratories

Astellas Pharma

AstraZeneca Plc

Bayer AG

Bristol Myers Squibb Company

Cipla Inc.

Dr. Reddy's Laboratories Ltd.

Eli Lilly and Company

F. Hoffmann-La Roche Ltd.

Gilead Sciences, Inc.

GlaxoSmithKline plc.

Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals)

Mayne Pharma Group Ltd.

MELINTA THERAPEUTICS, INC.

Merck KGaA

Novartis AG

Pfizer Inc.

Sanofi

Sun Pharmaceutical Industries Ltd.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Products


Companies

Key Players (this may not be a complete list and extra companies can be added upon request):

Abbott Laboratories

Astellas Pharma

AstraZeneca Plc

Bayer AG

Bristol Myers Squibb Company

Cipla Inc.

Dr. Reddy's Laboratories Ltd.

Eli Lilly and Company

F. Hoffmann-La Roche Ltd.

Gilead Sciences, Inc.

GlaxoSmithKline plc.

Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals)

Mayne Pharma Group Ltd.

MELINTA THERAPEUTICS, INC.

Merck KGaA

Novartis AG

Pfizer Inc.

Sanofi

Sun Pharmaceutical Industries Ltd.

Table Of Content

Table Of Content

1 Introduction 10

1.1 Industry Definition and Research Scope 10

1.1.1 Industry Definition 10

1.1.2 Research Scope 11

1.2 Research Methodology 14

1.2.1 Overview of Market Research Methodology 14

1.2.2 Market Assumption 15

1.2.3 Secondary Data 15

1.2.4 Primary Data 15

1.2.5 Data Filtration and Model Design 17

1.2.6 Market Size/Share Estimation 18

1.2.7 Research Limitations 19

1.3 Executive Summary 20

2 Market Overview and Dynamics 23

2.1 Market Size and Forecast 23

2.1.1 Impact of COVID-19 on the Market 24

2.2 Major Growth Drivers 26

2.3 Market Restraints and Challenges 30

2.4 Emerging Opportunities and Market Trends 33

2.5 Porter's Fiver Forces Analysis 37

3 Segmentation of Global Market by Drug Class 41

3.1 Market Overview by Drug Class 41

3.2 Cephalosporin 43

3.3 Penicillin 44

3.4 Macrolides 45

3.5 Fluoroquinolones 46

3.6 Quinolones 47

3.7 Monobactam 48

3.8 Aminoglycosides 49

3.9 Carbapenem 50

3.10 Other Drug Classes 51

4 Segmentation of Global Market by Action Mechanism 52

4.1 Market Overview by Action Mechanism 52

4.2 Cell Wall Synthesis Inhibitors 54

4.3 Mycolic Acid Inhibitors 55

4.4 RNA Synthesis Inhibitors 56

4.5 DNA Synthesis Inhibitors 57

4.6 Protein Synthesis Inhibitors 58

4.7 Other Mechanisms 59

5 Segmentation of Global Market by Drug Origin 60

5.1 Market Overview by Drug Origin 60

5.2 Natural Antibiotics 62

5.3 Semi-synthetic Antibiotics 63

5.4 Synthetic Antibiotics 64

6 Segmentation of Global Market by Activity Spectrum 65

6.1 Market Overview by Activity Spectrum 65

6.2 Broad-spectrum Antibiotics 67

6.3 Narrow-spectrum Antibiotics 68

7 Segmentation of Global Market by Route of Administration 69

7.1 Market Overview by Route of Administration 69

7.2 Oral Administration 71

7.3 Intravenous Administration 72

7.4 Other Administration Routes 73

8 Segmentation of Global Market by Drug Type 74

8.1 Market Overview by Drug Type 74

8.2 Brand Antibiotics 76

8.3 Generic Antibiotics 77

9 Segmentation of Global Market by Region 78

9.1 Geographic Market Overview 2019-2030 78

9.2 North America Market 2019-2030 by Country 84

9.2.1 Overview of North America Market 84

9.2.2 U.S. 88

9.2.3 Canada 92

9.2.4 Mexico 94

9.3 European Market 2019-2030 by Country 96

9.3.1 Overview of European Market 96

9.3.2 Germany 100

9.3.3 UK 102

9.3.4 France 104

9.3.5 Spain 106

9.3.6 Italy 108

9.3.7 Russia 110

9.3.8 Rest of European Market 112

9.4 Asia-Pacific Market 2019-2030 by Country 114

9.4.1 Overview of Asia-Pacific Market 114

9.4.2 Japan 118

9.4.3 China 121

9.4.4 Australia 123

9.4.5 India 125

9.4.6 South Korea 127

9.4.7 Rest of APAC Region 129

9.5 South America Market 2019-2030 by Country 131

9.5.1 Argentina 134

9.5.2 Brazil 136

9.5.3 Chile 138

9.5.4 Rest of South America Market 140

9.6 MEA Market 2019-2030 by Country 141

9.6.1 UAE 144

9.6.2 Saudi Arabia 146

9.6.3 South Africa 148

9.6.4 Other National Markets 150

10 Competitive Landscape 151

10.1 Overview of Key Vendors 151

10.2 New Product Launch, Partnership, Investment, and M&A 155

10.3 Company Profiles 156

Abbott Laboratories 156

Astellas Pharma 158

AstraZeneca Plc 159

Bayer AG 160

Bristol Myers Squibb Company 161

Cipla Inc. 162

Dr. Reddy's Laboratories Ltd. 163

Eli Lilly and Company 164

F. Hoffmann-La Roche Ltd. 165

Gilead Sciences, Inc. 166

GlaxoSmithKline plc. 167

Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals) 168

Mayne Pharma Group Ltd. 169

MELINTA THERAPEUTICS, INC. 170

Merck KGaA 171

Novartis AG 172

Pfizer Inc. 173

Sanofi 174

Sun Pharmaceutical Industries Ltd. 175

11 Investing in Global Market: Risk Assessment and Management 176

11.1 Risk Evaluation of Global Market 176

11.2 Critical Success Factors (CSFs) 179

Related Reports and Products 182


List Of Figure

Figure 1. Research Method Flow Chart 14

Figure 2. Breakdown of Primary Research 16

Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 18

Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 20

Figure 5. Global Antibiotics Market, 2019-2030, USD mn 23

Figure 6. Impact of COVID-19 on Business 24

Figure 7. Primary Drivers and Impact Factors of Global Antibiotics Market 26

Figure 8. GDP per capita in the World, 1960-2018, USD thousand 29

Figure 9. Forecast of Middle-class Population by Region, 2015-2030, million 29

Figure 10. Primary Restraints and Impact Factors of Global Antibiotics Market 30

Figure 11. Investment Opportunity Analysis 34

Figure 12. Porter's Fiver Forces Analysis of Global Antibiotics Market 37

Figure 13. Breakdown of Global Antibiotics Market by Drug Class, 2019-2030, % of Revenue 42

Figure 14. Global Addressable Market Cap in 2020-2030 by Drug Class, Value (USD mn) and Share (%) 42

Figure 15. Global Antibiotics Market: Cephalosporin, 2019-2030, USD mn 43

Figure 16. Global Antibiotics Market: Penicillin, 2019-2030, USD mn 44

Figure 17. Global Antibiotics Market: Macrolides, 2019-2030, USD mn 45

Figure 18. Global Antibiotics Market: Fluoroquinolones, 2019-2030, USD mn 46

Figure 19. Global Antibiotics Market: Quinolones, 2019-2030, USD mn 47

Figure 20. Global Antibiotics Market: Monobactam, 2019-2030, USD mn 48

Figure 21. Global Antibiotics Market: Aminoglycosides, 2019-2030, USD mn 49

Figure 22. Global Antibiotics Market: Carbapenem, 2019-2030, USD mn 50

Figure 23. Global Antibiotics Market: Other Drug Classes, 2019-2030, USD mn 51

Figure 24. Breakdown of Global Antibiotics Market by Action Mechanism, 2019-2030, % of Sales Revenue 53

Figure 25. Global Addressable Market Cap in 2020-2030 by Action Mechanism, Value (USD mn) and Share (%) 53

Figure 26. Global Antibiotics Market: Cell Wall Synthesis Inhibitors, 2019-2030, USD mn 54

Figure 27. Global Antibiotics Market: Mycolic Acid Inhibitors, 2019-2030, USD mn 55

Figure 28. Global Antibiotics Market: RNA Synthesis Inhibitors, 2019-2030, USD mn 56

Figure 29. Global Antibiotics Market: DNA Synthesis Inhibitors, 2019-2030, USD mn 57

Figure 30. Global Antibiotics Market: Protein Synthesis Inhibitors, 2019-2030, USD mn 58

Figure 31. Global Antibiotics Market: Other Mechanisms, 2019-2030, USD mn 59

Figure 32. Breakdown of Global Antibiotics Market by Drug Origin, 2019-2030, % of Sales Revenue 61

Figure 33. Global Addressable Market Cap in 2020-2030 by Drug Origin, Value (USD mn) and Share (%) 61

Figure 34. Global Antibiotics Market: Natural Antibiotics, 2019-2030, USD mn 62

Figure 35. Global Antibiotics Market: Semi-synthetic Antibiotics, 2019-2030, USD mn 63

Figure 36. Global Antibiotics Market: Synthetic Antibiotics, 2019-2030, USD mn 64

Figure 37. Breakdown of Global Antibiotics Market by Activity Spectrum, 2019-2030, % of Revenue 66

Figure 38. Global Addressable Market Cap in 2020-2030 by Activity Spectrum, Value (USD mn) and Share (%) 66

Figure 39. Global Antibiotics Market: Broad-spectrum Antibiotics, 2019-2030, USD mn 67

Figure 40. Global Antibiotics Market: Narrow-spectrum Antibiotics, 2019-2030, USD mn 68

Figure 41. Breakdown of Global Antibiotics Market by Route of Administration, 2019-2030, % of Revenue 70

Figure 42. Global Addressable Market Cap in 2020-2030 by Route of Administration, Value (USD mn) and Share (%) 70

Figure 43. Global Antibiotics Market: Oral Administration, 2019-2030, USD mn 71

Figure 44. Global Antibiotics Market: Intravenous Administration, 2019-2030, USD mn 72

Figure 45. Global Antibiotics Market: Other Administration Routes, 2019-2030, USD mn 73

Figure 46. Breakdown of Global Antibiotics Market by Drug Type, 2019-2030, % of Revenue 74

Figure 47. Global Addressable Market Cap in 2020-2030 by Drug Type, Value (USD bn) and Share (%) 75

Figure 48. Global Antibiotics Market: Brand Antibiotics, 2019-2030, USD bn 76

Figure 49. Global Antibiotics Market: Generic Antibiotics, 2019-2030, USD bn 77

Figure 50. Global Market Snapshot by Region 78

Figure 51. Geographic Spread of Worldwide Antibiotics Market, 2019-2030, % of Sales Revenue 79

Figure 52. Global Addressable Market Cap in 2020-2030 by Region, Value (USD bn) and Share (%) 80

Figure 53. Health Spending as a Share of GDP by Country, 2015 and 2030 82

Figure 54. North American Antibiotics Market, 2019-2030, USD bn 85

Figure 55. Breakdown of North America Antibiotics Market by Country, 2019 and 2030, % of Revenue 86

Figure 56. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value (USD bn) and Share (%) 87

Figure 57. U.S. Antibiotics Market, 2019-2030, USD bn 89

Figure 58. Rising Incidence of Infectious Disease in U.S. 89

Figure 59. Canada Antibiotics Market, 2019-2030, USD bn 92

Figure 60. Antibiotics Market in Mexico, 2015-2030, USD bn 94

Figure 61. European Antibiotics Market, 2019-2030, USD bn 97

Figure 62. Breakdown of European Antibiotics Market by Country, 2019 and 2030, % of Revenue 98

Figure 63. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value (USD bn) and Share (%) 99

Figure 64. Antibiotics Market in Germany, 2019-2030, USD bn 100

Figure 65. Antibiotics Market in UK, 2019-2030, USD bn 102

Figure 66. Antibiotics Market in France, 2019-2030, USD bn 104

Figure 67. Antibiotics Market in Spain, 2019-2030, USD bn 106

Figure 68. Antibiotics Market in Italy, 2019-2030, USD bn 108

Figure 69. Antibiotics Market in Russia, 2019-2030, USD bn 110

Figure 70. Antibiotics Market in Rest of Europe, 2019-2030, USD bn 112

Figure 71. Asia-Pacific Antibiotics Market, 2019-2030, USD bn 115

Figure 72. Breakdown of APAC Antibiotics Market by Country, 2019 and 2030, % of Revenue 115

Figure 73. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value (USD bn) and Share (%) 117

Figure 74. Antibiotics Market in Japan, 2019-2030, USD bn 119

Figure 75. Antibiotics Market in China, 2019-2030, USD bn 121

Figure 76. Antibiotics Market in Australia, 2019-2030, USD bn 123

Figure 77. Antibiotics Market in India, 2019-2030, USD bn 125

Figure 78. Antibiotics Market in South Korea, 2019-2030, USD bn 127

Figure 79. Antibiotics Market in Rest of APAC, 2019-2030, USD bn 129

Figure 80. South America Antibiotics Market, 2019-2030, USD bn 132

Figure 81. Breakdown of South America Antibiotics Market by Country, 2019 and 2030, % of Revenue 132

Figure 82. Contribution to South America 2020-2030 Cumulative Revenue by Country, Value (USD bn) and Share (%) 133

Figure 83. Antibiotics Market in Argentina, 2019-2030, USD bn 134

Figure 84. Antibiotics Market in Brazil, 2019-2030, USD bn 136

Figure 85. Antibiotics Market in Chile, 2019-2030, USD bn 138

Figure 86. Antibiotics Market in Rest of South America, 2019-2030, USD bn 140

Figure 87. Antibiotics Market in Middle East and Africa (MEA), 2019-2030, USD bn 142

Figure 88. Breakdown of MEA Antibiotics Market by Country, 2019 and 2030, % of Revenue 142

Figure 89. Contribution to MEA 2020-2030 Cumulative Revenue by Country, Value (USD bn) and Share (%) 143

Figure 90. Antibiotics Market in UAE, 2019-2030, USD bn 144

Figure 91. Antibiotics Market in Saudi Arabia, 2019-2030, USD bn 146

Figure 92. Antibiotics Market in South Africa, 2019-2030, USD bn 148

Figure 93. Growth Stage of Global Antibiotics Industry over the Forecast Period 151


List Of Table

Table 1. Snapshot of Global Antibiotics Market, 2019-2030 21

Table 2. Main Product Trends and Market Opportunities in Global Antibiotics Market 33

Table 3. Global Antibiotics Market by Drug Class, 2019-2030, USD mn 41

Table 4. Global Antibiotics Market by Action Mechanism, 2019-2030, USD mn 52

Table 5. Global Antibiotics Market by Drug Origin, 2019-2030, USD mn 60

Table 6. Global Antibiotics Market by Activity Spectrum, 2019-2030, USD mn 65

Table 7. Global Antibiotics Market by Route of Administration, 2019-2030, USD mn 69

Table 8. Global Antibiotics Market by Drug Type, 2019-2030, USD bn 74

Table 9. Global Antibiotics Market by Region, 2019-2030, USD bn 79

Table 10. Total Health Expenditure per capita in PPP International U.S. Dollars by Country 81

Table 11. Leading National Antibiotics Market, 2019 and 2030, USD bn 83

Table 12. North America Antibiotics Market by Country, 2019-2030, USD bn 86

Table 13. U.S. Antibiotics Market by Drug Class, 2019-2030, USD mn 90

Table 14. U.S. Antibiotics Market by Drug Origin, 2019-2030, USD mn 90

Table 15. U.S. Antibiotics Market by Route of Administration, 2019-2030, USD mn 90

Table 16. Canada Antibiotics Market by Drug Class, 2019-2030, USD mn 93

Table 17. Canada Antibiotics Market by Drug Origin, 2019-2030, USD mn 93

Table 18. Canada Antibiotics Market by Route of Administration, 2019-2030, USD mn 93

Table 19. Mexico Antibiotics Market by Drug Class, 2019-2030, USD mn 95

Table 20. Mexico Antibiotics Market by Drug Origin, 2019-2030, USD mn 95

Table 21. Mexico Antibiotics Market by Route of Administration, 2019-2030, USD mn 95

Table 22. Europe Antibiotics Market by Country, 2019-2030, USD bn 99

Table 23. Germany Antibiotics Market by Drug Class, 2019-2030, USD mn 101

Table 24. Germany Antibiotics Market by Drug Origin, 2019-2030, USD mn 101

Table 25. Germany Antibiotics Market by Route of Administration, 2019-2030, USD mn 101

Table 26. UK Antibiotics Market by Drug Class, 2019-2030, USD mn 103

Table 27. UK Antibiotics Market by Drug Origin, 2019-2030, USD mn 103

Table 28. UK Antibiotics Market by Route of Administration, 2019-2030, USD mn 103

Table 29. France Antibiotics Market by Drug Class, 2019-2030, USD mn 105

Table 30. France Antibiotics Market by Drug Origin, 2019-2030, USD mn 105

Table 31. France Antibiotics Market by Route of Administration, 2019-2030, USD mn 105

Table 32. Spain Antibiotics Market by Drug Class, 2019-2030, USD mn 107

Table 33. Spain Antibiotics Market by Drug Origin, 2019-2030, USD mn 107

Table 34. Spain Antibiotics Market by Route of Administration, 2019-2030, USD mn 107

Table 35. Italy Antibiotics Market by Drug Class, 2019-2030, USD mn 109

Table 36. Italy Antibiotics Market by Drug Origin, 2019-2030, USD mn 109

Table 37. Italy Antibiotics Market by Route of Administration, 2019-2030, USD mn 109

Table 38. Russia Antibiotics Market by Drug Class, 2019-2030, USD mn 111

Table 39. Russia Antibiotics Market by Drug Origin, 2019-2030, USD mn 111

Table 40. Russia Antibiotics Market by Route of Administration, 2019-2030, USD mn 111

Table 41. Antibiotics Market in Rest of Europe by Country, 2019-2030, USD bn 113

Table 42. APAC Antibiotics Market by Country, 2019-2030, USD bn 116

Table 43. Japan Antibiotics Market by Drug Class, 2019-2030, USD mn 120

Table 44. Japan Antibiotics Market by Drug Origin, 2019-2030, USD mn 120

Table 45. Japan Antibiotics Market by Route of Administration, 2019-2030, USD mn 120

Table 46. China Antibiotics Market by Drug Class, 2019-2030, USD mn 122

Table 47. China Antibiotics Market by Drug Origin, 2019-2030, USD mn 122

Table 48. China Antibiotics Market by Route of Administration, 2019-2030, USD mn 122

Table 49. Australia Antibiotics Market by Drug Class, 2019-2030, USD mn 124

Table 50. Australia Antibiotics Market by Drug Origin, 2019-2030, USD mn 124

Table 51. Australia Antibiotics Market by Route of Administration, 2019-2030, USD mn 124

Table 52. India Antibiotics Market by Drug Class, 2019-2030, USD mn 126

Table 53. India Antibiotics Market by Drug Origin, 2019-2030, USD mn 126

Table 54. India Antibiotics Market by Route of Administration, 2019-2030, USD mn 126

Table 55. South Korea Antibiotics Market by Drug Class, 2019-2030, USD mn 128

Table 56. South Korea Antibiotics Market by Drug Origin, 2019-2030, USD mn 128

Table 57. South Korea Antibiotics Market by Route of Administration, 2019-2030, USD mn 128

Table 58. Antibiotics Market in Rest of APAC by Country, 2019-2030, USD bn 130

Table 59. South America Antibiotics Market by Country, 2019-2030, USD bn 133

Table 60. Argentina Antibiotics Market by Drug Class, 2019-2030, USD mn 135

Table 61. Argentina Antibiotics Market by Drug Origin, 2019-2030, USD mn 135

Table 62. Argentina Antibiotics Market by Route of Administration, 2019-2030, USD mn 135

Table 63. Brazil Antibiotics Market by Drug Class, 2019-2030, USD mn 137

Table 64. Brazil Antibiotics Market by Drug Origin, 2019-2030, USD mn 137

Table 65. Brazil Antibiotics Market by Route of Administration, 2019-2030, USD mn 137

Table 66. Chile Antibiotics Market by Drug Class, 2019-2030, USD mn 139

Table 67. Chile Antibiotics Market by Drug Origin, 2019-2030, USD mn 139

Table 68. Chile Antibiotics Market by Route of Administration, 2019-2030, USD mn 139

Table 69. MEA Antibiotics Market by Country, 2019-2030, USD bn 143

Table 70. UAE Antibiotics Market by Drug Class, 2019-2030, USD mn 145

Table 71. UAE Antibiotics Market by Drug Origin, 2019-2030, USD mn 145

Table 72. UAE Antibiotics Market by Route of Administration, 2019-2030, USD mn 145

Table 73. Saudi Arabia Antibiotics Market by Drug Class, 2019-2030, USD mn 147

Table 74. Saudi Arabia Antibiotics Market by Drug Origin, 2019-2030, USD mn 147

Table 75. Saudi Arabia Antibiotics Market by Route of Administration, 2019-2030, USD mn 147

Table 76. South Africa Antibiotics Market by Drug Class, 2019-2030, USD mn 149

Table 77. South Africa Antibiotics Market by Drug Origin, 2019-2030, USD mn 149

Table 78. South Africa Antibiotics Market by Route of Administration, 2019-2030, USD mn 149

Table 79. Breakdown of Global Market by Key Vendor, 2019, % 153

Table 80. Abbott Laboratories: Company Snapshot 156

Table 81. Abbott Laboratories: Business Segmentation 156

Table 82. Abbott Laboratories: Product Portfolio 157

Table 83. Abbott Laboratories: Revenue, 2016-2018, USD mn 157

Table 84. Abbott Laboratories: Recent Developments 157

Table 85. Risk Evaluation for Investing in Global Market, 2019-2030 177

Table 86. Critical Success Factors and Key Takeaways 180

You can also purchase parts of this report. Do you want to check out a section wise price list?

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

408564 Reports in repository
150+ Consulting project
100+ Analysts
8000+ Client Queries in 2022